Publisher: John Wiley & Sons Inc
E-ISSN: 1532-6535|93|3|242-244
ISSN: 0009-9236
Source: CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol.93, Iss.3, 2013-03, pp. : 242-244
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
HER-Targeted Tyrosine-Kinase Inhibitors
Oncology, Vol. 63, Iss. 1, 2002-11 ,pp. :
Tyrosine Kinase Inhibitors Enhance Ciprofloxacin-Induced Phototoxicity by Inhibiting ABCG2
Oncology, Vol. 87, Iss. 6, 2014-09 ,pp. :
Bruton's tyrosine kinase inhibitors in B‐cell non‐Hodgkin's lymphomas
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 5, 2015-05 ,pp. :
Treating Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors
Acta Haematologica, Vol. 130, Iss. 3, 2013-06 ,pp. :